These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 22931632

  • 1. [Clinical significance of CD34(+)CD38(+) and CD34(+)CD38(low/-) subgroups in bone marrow of patients with B lymphoblastic leukemia].
    Hao L, Liu YR, Wang YZ, Chang Y, Qin YZ, Li JL, Li LD, Huang XJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):801-5. PubMed ID: 22931632
    [Abstract] [Full Text] [Related]

  • 2. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia].
    Liu Y, Tang JY, Xu C, Gu LJ, Xue HL, Chen J, Pan C, Dong L, Zhou M.
    Zhonghua Er Ke Za Zhi; 2009 May; 47(5):366-70. PubMed ID: 19573409
    [Abstract] [Full Text] [Related]

  • 6. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
    Burnusuzov HA, Spasova MI, Murdjeva MA, Stoyanova AA, Mumdziev IN, Kaleva VI, Belcheva MI, Bosheva MN.
    Folia Med (Plovdiv); 2016 Mar 01; 58(1):28-35. PubMed ID: 27383875
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Proportions of cells expressing CD38-/CD34+, CD38+/CD34+, CD19+/CD34+, or CD13,33+/CD34+ in the regenerating bone marrows during complete remission of acute leukemia or after bone marrow transplantation].
    Kahng J, Shin SY, Han K.
    Korean J Lab Med; 2007 Dec 01; 27(6):406-13. PubMed ID: 18160830
    [Abstract] [Full Text] [Related]

  • 9. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
    van Rhenen A, Moshaver B, Kelder A, Feller N, Nieuwint AW, Zweegman S, Ossenkoppele GJ, Schuurhuis GJ.
    Leukemia; 2007 Aug 01; 21(8):1700-7. PubMed ID: 17525725
    [Abstract] [Full Text] [Related]

  • 10. [Immunophenotypic features of bcr/abl fusion transcript-positive B-lineage acute lymphoblast leukemia].
    Li JL, Liu YR, Qin YZ, Chang Y, Fu JY, Wang H, Ruan GR, Chen SS.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr 01; 11(2):142-5. PubMed ID: 12744735
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L, López O, Martino R, Brunet S, Bellido M, Rubiol E, Sierra J, Nomdedéu JF.
    Haematologica; 2000 Jul 01; 85(7):704-10. PubMed ID: 10897122
    [Abstract] [Full Text] [Related]

  • 13. [Proportion of CD34(+)CD38(-) cell population in bone marrow of patients with de novo AML as prognostic factor of complete remission at first course of induction chemotherapy].
    Zhang CP, Wei H, Wang HJ, Huai L, He K, Chen YR, Lin D, Wang JX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct 01; 19(5):1268-72. PubMed ID: 22040986
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse].
    Liu YR, Chang Y, Fu JY, Cheng YF, Zhang LP, Li LD, Wang H, Liu GL, Chen SS, Huang XJ, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 May 01; 27(5):335-8. PubMed ID: 16875586
    [Abstract] [Full Text] [Related]

  • 15. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 May 01; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 16. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
    Zha W, Yuan Y, Yang T, Zhu LJ, Kong WY, Zhuo JJ.
    Eur Rev Med Pharmacol Sci; 2024 May 01; 28(9):3384-3390. PubMed ID: 38766795
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
    Xia M, Zhang H, Lu Z, Gao Y, Liao X, Li H.
    J Pediatr Hematol Oncol; 2016 Aug 01; 38(6):418-22. PubMed ID: 27438018
    [Abstract] [Full Text] [Related]

  • 19. Immunophenotypic shift in the B-cell precursors from regenerating bone marrow samples: A critical consideration for measurable residual disease assessment in B-lymphoblastic leukemia.
    Chatterjee G, Sriram H, Ghogale S, Deshpande N, Khanka T, Panda D, Pradhan SN, Girase K, Narula G, Dhamane C, Malik NR, Banavali S, Patkar NV, Gujral S, Subramanian PG, Tembhare PR.
    Cytometry B Clin Cytom; 2021 Jul 01; 100(4):434-445. PubMed ID: 32896101
    [Abstract] [Full Text] [Related]

  • 20. High frequency of immature cells at diagnosis predicts high minimal residual disease level in childhood acute lymphoblastic leukemia.
    Ebinger M, Witte KE, Ahlers J, Schäfer I, André M, Kerst G, Scheel-Walter HG, Lang P, Handgretinger R.
    Leuk Res; 2010 Sep 01; 34(9):1139-42. PubMed ID: 20378168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.